As Angptl8 promoted macrophage migration to the liver, we wondered whether a reduction in hepatic ANGPTL8 could inhibit the development of CDHFD-induced NASH. This evidence concerns the gene ANGPTL8 and metabolic dysfunction-associated steatohepatitis.